Prevalence and Antibiotic Susceptibility of Proteus mirabilis Isolated from Clinical Specimens in the Zainoel Abidin General Hospital, Banda Aceh, Indonesia

Suhartono Suhartono; Wilda Mahdani; Khalizazia Khalizazia

doi:10.3889/oamjms.2022.10695

Authors

Suhartono Suhartono Department of Biology, Faculty of Mathematics and Natural Sciences, Universitas Syiah Kuala, Aceh 23111, Indonesia https://orcid.org/0000-0002-1052-0443
Wilda Mahdani Department of Microbiology, Faculty of Medicine, Universitas Syiah Kuala, Aceh 23111, Indonesia
Khalizazia Khalizazia Department of Biology, Faculty of Mathematics and Natural Sciences, Universitas Syiah Kuala, Aceh 23111, Indonesia

DOI:

https://doi.org/10.3889/oamjms.2022.10695

Keywords:

Proteus mirabilis, Clinical specimens, Distribution, Antibiotic susceptibility, Prevalence

Abstract

BACKGROUND: Proteus mirabilis is Gram-negative bacteria from the Enterobacteriaceae family causing various infections.

AIM: This study aimed to determine the prevalence and distribution of Proteus mirabilis isolated from clinical specimens based on patients’ age, gender, type of specimen, and patient wards and their antibiotic sensitivity.

METHODS: This study involved isolating, identifying, and testing antibiotic susceptibility to Proteus mirabilis isolates recoverred from clinical specimens of dr. Zainoel Abidin general hospital Banda Aceh during March 2020-March 2022.

RESULTS: This study showed that 121 isolates of Proteus mirabilis were obtained from clinical specimens during the study with prevalence of almost 2%. Proteus mirabilis distribution based on the specimen type was most predominantly found in pus specimens and from patients in the the operating room and post surgery ward accounting for 84.29% and 35.53%. Proteus mirabilis was detected most frequently in individuals aged 46-55 years old (30.57 %), whereas it was found more frequently in men (71%) based on gender. The susceptibility of Proteus mirabilis to antibiotics was highest to cefoperazone, piperacillin/tazobactam, and amikacin reaching reaching 97.5%, 97.5, and 96.66%, respectively.

CONCLUSION: The distribution of Proteus mirabilis isolates predominantly in pus specimens indicating its association with wound infections. Despite some antibiotics remain effective, implementation of the regular surveillance programs along with rational use of antibiotics may prevent the bacterial pathogen to spread particularly within healthcare settings.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Armbruster CE, Mobley HL, Pearson MM, Donnenberg MS. Pathogenesis of Proteus mirabilis infection. EcoSal Plus. 2018;8(1):1-73. https://doi.org/10.1128/ecosalplus.esp-0009-2017 PMid:29424333 DOI: https://doi.org/10.1128/ecosalplus.ESP-0009-2017

Hasan TH, Alasedi KK, Jaloob AA. Proteus mirabilis virulence factors. Int J Pharm Res. 2021;13(1):2145-9. https://doi.org/10.31838/ijpr/2021.13.01.169 DOI: https://doi.org/10.31838/ijpr/2021.13.01.169

Yuan F, Huang Z, Yang T, Wang G, Li P, Yang B, et al. Pathogenesis of Proteus mirabilis in catheter-associated urinary tract infections. Urol Int. 2021;105(5-6):354-61. https://doi.org/10.1159/000514097 PMid:33691318 DOI: https://doi.org/10.1159/000514097

Baldo C, Rocha SP. Virulence factors of uropathogenic Proteus mirabilis - A mini review. Int J Sci Res. 2014;3:24-7.

Wasfi R, Hamed SM, Amer MA, Fahmy LI. Proteus mirabilis biofilm: Development and therapeutic strategies. Front Cell Infect Microbiol. 2020;10:414. https://doi.org/10.3389/fcimb.2020.00414 PMid:32923408 DOI: https://doi.org/10.3389/fcimb.2020.00414

Mishu NJ, Shamsuzzaman S, Khaleduzzaman H, Nabonee MA, Dola NZ, Haque A. Association between biofilm formation and virulence genes expression and antibiotic resistance pattern in Proteus mirabilis, isolated from patients of Dhaka medical college hospital. Arch Clin Biomed Res. 2022;6:418-34. https://doi.org/10.26502/acbr.50170257 DOI: https://doi.org/10.26502/acbr.50170257

Pincus DH. Microbial identification using the bioMérieux Vitek® 2 system. In: Encyclopedia of Rapid Microbiological Methods. Bethesda, MD: Parenteral Drug Association; 2006. p. 1-32.

Little K, Austerman J, Zheng J, Gibbs KA, O’Toole G. Cell shape and population migration are distinct steps of Proteus mirabilis swarming that are decoupled on high-percentage agar. J Bacteriol. 2019;201(11):e00726-18. https://doi.org/10.1128/jb.00726-18 PMid:30858303 DOI: https://doi.org/10.1128/JB.00726-18

Khodair HI, Al-Asady ZH. Molecular detection of Proteus mirabilis isolated from diabetic foot. Ann Rom Soc Cell Biol. 2021;25(1):6615-23.

Pandey JK, Narayan A, Tyagi S. Prevalence of Proteus species in clinical samples, antibiotic sensitivity pattern and ESBL production. Int J Curr Microbiol Appl Sci. 2013;2(10):253-61.

Sharma V, Parihar G, Sharma V, Sharma H. A study of various isolates from pus sample with their antibiogram from Jln hospital, Ajmer. IOSR J Dent Med Sci. 2015;14(10):64-8. https://doi.org/10.20546/ijcmas.2019.806.308 DOI: https://doi.org/10.20546/ijcmas.2019.806.308

Kamil TD, Jarjes SF. Isolation, identification, and antibiotics susceptibility determination of Proteus species obtained from various clinical specimens in Erbil city. Polytech J. 2019;9(2):86-92. https://doi.org/10.25156/ptj.v9n2y2019.pp86-92 DOI: https://doi.org/10.25156/ptj.v9n2y2019.pp86-92

Merdaw MA. Postoperative wound infections and the antimicrobial susceptibility in Baghdad hospitals. Iraqi J Pharm Sci. 2011;20(2):59-65. https://doi.org/10.31351/vol20iss2pp59-65 DOI: https://doi.org/10.31351/vol20iss2pp59-65

Zafar U, Taj MK, Nawaz I, Zafar A, Taj I. Characterization of Proteus mirabilis isolated from patient wounds at Bolan medical complex hospital, Quetta. Jundishapur J Microbiol. 2019;12(7):e87963. https://doi.org/10.5812/jjm.87963 DOI: https://doi.org/10.5812/jjm.87963

Bahashwan SA, El Shafey HM. Antimicrobial resistance patterns of Proteus isolates from clinical specimens. Eur Sci J. 2013;9(27): 188-202. https://doi.org/10.19044/esj.2013.v9n27p%25p

Hassen TF. Study of Proteus mirabilis infections in Al-Nassiria city. J Thi Qar Unv. 2008;1(3):9-17. https://doi.org/10.32792/utq/utjsci/vol1/1/6 DOI: https://doi.org/10.32792/utq/utjsci/vol1/1/6

Tom IM, Agbo E, Faruk UA, Umoru AM, Ibrahim MM, Umar JB, et al. Implication of Proteus spp in the pathology of nosocomial wound infection in Northeastern nigeria. Int J Pathogen Res. 2018;9:1-8. https://doi.org/10.9734/ijpr/2018/v1i21258 DOI: https://doi.org/10.9734/ijpr/2018/v1i21258

Chen CY, Chen YH, Lu PL, Lin WR, Chen TC, Lin CY. Proteus mirabilis urinary tract infection and bacteremia: Risk factors, clinical presentation, and outcomes. J Microbiol Immunol Infect. 2012;45(3):228-36. https://doi.org/10.1016/j.jmii.2011.11.007 PMid:22572004 DOI: https://doi.org/10.1016/j.jmii.2011.11.007

Bean DC, Livermore DM, Hall LM. Plasmids imparting sulfonamide resistance in Escherichia coli: Implications for persistence. Antimicrob Agents Chemother. 2009;53(3):1088-93. https://doi.org/10.1128/aac.00800-08 PMid:19075061 DOI: https://doi.org/10.1128/AAC.00800-08

Lin MF, Liou ML, Kuo CH, Lin YY, Chen JY, Kuo HY. Antimicrobial susceptibility and molecular epidemiology of Proteus mirabilis isolates from three hospitals in Northern Taiwan. Microb Drug Resist. 2019;25(9):1338-46. https://doi.org/10.1089/mdr.2019.0066 PMid:31295061 DOI: https://doi.org/10.1089/mdr.2019.0066